Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes

Abstract : BACKGROUND: Recent advances in nanomedicine have shown the great interest of active targeting associated to nanoparticles. Single chain variable fragments (scFv) of disease-specific antibodies are very promising targeting entities because they are small, not immunogenic and able to bind their specific antigens. The present paper is devoted to biological properties in vitro and in vivo of fluorescent and pegylated iron oxide nanoparticles (SPIONs-Cy-PEG-scFv) functionalized with scFv targeting Human Epithelial growth Receptor 2 (HER2). RESULTS: Thanks to a site-selective scFv conjugation, the resultant nanoprobes demonstrated high affinity and specific binding to HER2 breast cancer cells. The cellular uptake of SPIONs-Cy-PEG-scFv was threefold higher than that for untargeted PEGylated iron oxide nanoparticles (SPIONs-Cy-PEG) and is correlated to the expression of HER2 on cells. In vivo, the decrease of MR signals in HER2+ xenograft tumor is about 30% at 24 h after the injection. CONCLUSIONS: These results all indicate that SPIONs-Cy-PEG-scFv are relevant tumor-targeting magnetic resonance imaging agents, suitable for diagnosis of HER2 overexpressing breast tumor.
Liste complète des métadonnées

Littérature citée [31 références]  Voir  Masquer  Télécharger

https://hal-univ-tours.archives-ouvertes.fr/hal-01808604
Déposant : Martin Soucé <>
Soumis le : mardi 26 mai 2020 - 23:13:44
Dernière modification le : vendredi 9 octobre 2020 - 18:32:18

Fichier

2018_Alric_Journal of Nanobiot...
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Distributed under a Creative Commons Paternité 4.0 International License

Identifiants

Collections

Citation

Christophe Alric, Katel Hervé-Aubert, Nicolas Aubrey, Souad Melouk, Laurie Lajoie, et al.. Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes. Journal of Nanobiotechnology, BioMed Central, 2018, 16 (18), ⟨10.1186/s12951-018-0341-6⟩. ⟨hal-01808604⟩

Partager

Métriques

Consultations de la notice

236

Téléchargements de fichiers

69